Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 3Phase 4 1

Status

Completed 3Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Tumor-Agnostic 3Genitourinary 2Sarcoma 1CNS 1

Conditions

Neoplasms 6Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Influenza, Human 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Sarcoma 1Recurrence 1Psoriasis 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Melanoma 1Medullary cystic kidney disease 1 1Lung Neoplasms 1Glioblastoma 1Epstein-Barr Virus Infections 1Diabetes Mellitus, Insulin-Dependent, 12 1Crohn Disease 1Condylomata Acuminata 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Vaccines × Clear all
NCT04948619 2026-01-22

Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients

Wake Forest University Health Sciences

Phase 2 Recruiting
64 enrolled
Tumor-Agnostic

Neoplasms

NCT06175221 2025-09-15

Autologous TLPO Vaccine Basket

Elios Therapeutics, LLC

Phase 2 Terminated
63 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT00505063 2025-06-15

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
76 enrolled
Tumor-Agnostic

Neoplasms

NCT05986981 2023-08-14

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Peking Union Medical College Hospital

Phase 2 Unknown
20 enrolled
Genitourinary

Medullary cystic kidney disease 1, Neoplasms

NCT00405327 2017-11-06

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

University of Michigan Rogel Cancer Center

Phase 2 Completed
16 enrolled
CNSGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Sarcoma

NCT01205581 2016-09-23

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

St. Jude Children's Research Hospital

Phase 2 Completed
85 enrolled 24 charts

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡